Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study.

[1]  D. Hoban,et al.  Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study. , 2010, Surgical infections.

[2]  S. Mccormick,et al.  Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  Ronald N. Jones,et al.  Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007). , 2009, Diagnostic microbiology and infectious disease.

[4]  J. Bertino,et al.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics , 2009, Clinical ophthalmology.

[5]  T. Morris,et al.  Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria , 2009, Antimicrobial Agents and Chemotherapy.

[6]  A. Evangelista,et al.  Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005. , 2008, Postgraduate medicine.

[7]  M. Raizman,et al.  Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. , 2008, American journal of ophthalmology.

[8]  P. Asbell,et al.  Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the United States: 2000 to 2005 , 2008, Journal of cataract and refractive surgery.

[9]  C. Mcstay,et al.  Ocular infection and inflammation. , 2008, Emergency medicine clinics of North America.

[10]  J. Whitcher,et al.  Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. , 2007, American journal of ophthalmology.

[11]  Ronald N. Jones,et al.  Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). , 2007, Diagnostic microbiology and infectious disease.

[12]  M. Willcox,et al.  Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. , 2007, Optometry and vision science : official publication of the American Academy of Optometry.

[13]  Ronald N. Jones,et al.  Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). , 2006, Diagnostic microbiology and infectious disease.

[14]  Ronald N. Jones,et al.  Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003). , 2006, Diagnostic microbiology and infectious disease.

[15]  G. French.  Clinical impact and relevance of antibiotic resistance. , 2005, Advanced drug delivery reviews.

[16]  A. Evangelista,et al.  Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  A. Evangelista,et al.  Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Evangelista,et al.  Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network. , 2002, International journal of antimicrobial agents.

[19]  R. Armstrong.  The microbiology of the eye , 2000, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.

[20]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[21]  J. Leeming.  Treatment of Ocular Infections with Topical Antibacterials , 1999, Clinical pharmacokinetics.

[22]  P. Fedorka-Cray,et al.  Public health aspects of antibiotic resistance monitoring in the USA. , 1999, Acta veterinaria Scandinavica. Supplementum.

[23]  Kasik Je.  Vancomycin: specialized niche for a narrow-spectrum antibiotic. , 1988 .